Our results are also in agreement with literature data showing a role for JAK/STAT pathway in the modulation of liver fibrosis, as in the case of STAT3 activation in hepatic stellate cells treated with IL-6 and leptin [30,31]. The gene discussed is STAT3; the disease is Hepatic fibrosis.